Angels in MedCity
VC Fund
London, United Kingdom
Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Angels in MedCity invests in
Stages Angels in MedCity invests in
Countries Angels in MedCity invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $482k–$2M
- Angel
- $313k–$1.2M
Investment Focus
Industry
- Health Care 11 (55%)
- Biotechnology 10 (50%)
- Medical 6 (30%)
- Life Science 6 (30%)
- Medical Device 6 (30%)
Stage
- Seed 7 (35%)
- Funding Round 5 (25%)
- Angel 3 (15%)
- Pre-Seed 1 (5%)
- Series A 1 (5%)
Country
- United Kingdom 16 (80%)
- United States 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Nicholas Ibery
Angel Investor
|
Angel Investor | Total investments: 0 | Find email | |
Patrick O'Brien
Project Manager
|
Project Manager | Total investments: 1 | Find email | |
Patrick O'Brien
Project Manager
|
Project Manager | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Clustermarket is the world’s leading operating system for life-sciences laboratories. Our goal is to bring the management of research into the digital age, democratise access to expensive equipment and services and ultimately to enable life sciences innovators to get ideas to market faster than ever before. Our award-winning lab management software(previously known as Bookkit) and revolutionary marketplace helps labs to manage, connect and share resources. | $1.1M / Angel / Nov 01, 2019 | ||
| Clustermarket enables lab managers and operations teams to organize and schedule the use of shared equipment through a centralized system. Calira helps users replace manual tracking tools such as spreadsheets and shared calendars by offering real-time visibility into equipment availability, usage, and location. Its system supports efficientcoordination among research teams, reducing scheduling conflicts and downtime. | $1.2M / Angel / Nov 01, 2019 | ||
| Atelerix has a transformative technology for the storage and transport of viable cells at room temperature, overcoming the barriers and limitations presented by the current need for cryo-shipping. We do this using our patented process of encapsulating the cells in a natural hydrogel for safe shipment and storage. The cells can be recovered whenneeded by the addition of a gentle, cell-friendly buffer. This means: Predictability and reliability in drug discovery models and for cells used as therapies Customers can use cells and assays immediately on arrival No need for cryopreservation, nor need for cytotoxic or animal-derived supplements Cells retain their natural state and are not damaged nor altered | $482K / Seed / Apr 30, 2018 | ||
| DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses. | $841.8K / Seed / Apr 28, 2017 | ||
| Clustermarket is the world’s leading operating system for life-sciences laboratories. Our goal is to bring the management of research into the digital age, democratise access to expensive equipment and services and ultimately to enable life sciences innovators to get ideas to market faster than ever before. Our award-winning lab management software(previously known as Bookkit) and revolutionary marketplace helps labs to manage, connect and share resources. | Angel / Apr 13, 2017 | ||
| Clustermarket enables lab managers and operations teams to organize and schedule the use of shared equipment through a centralized system. Calira helps users replace manual tracking tools such as spreadsheets and shared calendars by offering real-time visibility into equipment availability, usage, and location. Its system supports efficientcoordination among research teams, reducing scheduling conflicts and downtime. | $312.6K / Angel / Apr 13, 2017 | ||
| LiveSmart provides health assessments and reacted quickly to the new situation. The team sourced and supplied antibody tests via their well-established platform; supporting both small businesses and large corporate clients. | $870.8K / Seed / Mar 29, 2017 | ||
| Accurx is where conversations happen with and about patients. Through one, easy-to-use platform, we help everyone involved in a patient’s care to communicate and collaborate.Whether you’re a patient or a healthcare professional, Accurx lets you connect seamlessly with the people you need to. You can use Accurx to: send SMS messages and medicalsurveys, provide appointment reminders and referrals, hold video consultations, and manage virtual wards, outpatient clinics and follow-up pathways.Accurx is used by 98% of GP practices and in 50% of NHS trusts. | $415.3K / Pre-Seed / Mar 17, 2017 | ||
| The Electrospinning Company is a leading edge provider of electrospun nanofibre innovations, developing solutions to industrial challenges. They also work closely with academic research groups to develop novel nano-scale fibres and coatings for scientific research. | $823K / Angel / Feb 01, 2017 | ||
| Jupiter Diagnostics offers a faster, cheaper way to obtain accurate blood tests. Our patent- protected reader can replace the lab, delivering multiple tests in 10 minutes, from a prick of blood, at prices a third cheaper. | $2.1M / Jan 23, 2017 | ||
| See all 20 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Angels in MedCity invest in?
Angels in MedCity invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Funding Round stage. Most of the 20 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Angels in MedCity's check size?
Angels in MedCity typically joins rounds of $482k–$2M at Seed and $313k–$1.2M at Angel. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Angels in MedCity participates in.
How do I contact Angels in MedCity?
Public channels for Angels in MedCity include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Angels in MedCity?
The team at Angels in MedCity includes Nicholas Ibery (Angel Investor), Patrick O'Brien (Project Manager) and Patrick O'Brien (Project Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
